Compile Data Set for Download or QSAR
Report error Found 56 Enz. Inhib. hit(s) with all data for entry = 50015055
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582250(CHEMBL5075301)
Affinity DataIC50: 2nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582248(CHEMBL5076447)
Affinity DataIC50: 3nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582258(CHEMBL5094640)
Affinity DataIC50: 3nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582254(CHEMBL5088588)
Affinity DataIC50: 4nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582251(CHEMBL5079990)
Affinity DataIC50: 5nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582262(CHEMBL5087788)
Affinity DataIC50: 5nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582257(CHEMBL5079737)
Affinity DataIC50: 5nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582249(CHEMBL5090193)
Affinity DataIC50: 6nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582265(CHEMBL5091192)
Affinity DataIC50: 6nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582248(CHEMBL5076447)
Affinity DataIC50: 8nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582264(CHEMBL5093825)
Affinity DataIC50: 8nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582260(CHEMBL5077968)
Affinity DataIC50: 9nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582253(CHEMBL5071152)
Affinity DataIC50: 10nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582252(CHEMBL5085979)
Affinity DataIC50: 10nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582266(CHEMBL5094876)
Affinity DataIC50: 10nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582250(CHEMBL5075301)
Affinity DataIC50: 11nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582255(CHEMBL5082615)
Affinity DataIC50: 11nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582249(CHEMBL5090193)
Affinity DataIC50: 11nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582272(CHEMBL5084123)
Affinity DataIC50: 12nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582259(CHEMBL5091399)
Affinity DataIC50: 13nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582261(CHEMBL5091019)
Affinity DataIC50: 14nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582258(CHEMBL5094640)
Affinity DataIC50: 17nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582273(CHEMBL5085200)
Affinity DataIC50: 18nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582256(CHEMBL5087312)
Affinity DataIC50: 19nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582254(CHEMBL5088588)
Affinity DataIC50: 24nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582270(CHEMBL5084495)
Affinity DataIC50: 25nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582274(CHEMBL5073141)
Affinity DataIC50: 25nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582267(CHEMBL5082986)
Affinity DataIC50: 26nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582271(CHEMBL5080176)
Affinity DataIC50: 26nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582251(CHEMBL5079990)
Affinity DataIC50: 27nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582263(CHEMBL5094391)
Affinity DataIC50: 33nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582275(CHEMBL5081576)
Affinity DataIC50: 37nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582262(CHEMBL5087788)
Affinity DataIC50: 48nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582257(CHEMBL5079737)
Affinity DataIC50: 56nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582261(CHEMBL5091019)
Affinity DataIC50: 94nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582259(CHEMBL5091399)
Affinity DataIC50: 100nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582273(CHEMBL5085200)
Affinity DataIC50: 100nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582268(CHEMBL5085436)
Affinity DataIC50: 103nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582265(CHEMBL5091192)
Affinity DataIC50: 120nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582264(CHEMBL5093825)
Affinity DataIC50: 160nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582252(CHEMBL5085979)
Affinity DataIC50: 170nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetInterleukin-1 receptor-associated kinase 4(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582269(CHEMBL5090869)
Affinity DataIC50: 179nMAssay Description:Inhibition of IRAK4 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582253(CHEMBL5071152)
Affinity DataIC50: 230nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582266(CHEMBL5094876)
Affinity DataIC50: 230nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582267(CHEMBL5082986)
Affinity DataIC50: 250nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582274(CHEMBL5073141)
Affinity DataIC50: 270nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582271(CHEMBL5080176)
Affinity DataIC50: 280nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582268(CHEMBL5085436)
Affinity DataIC50: 380nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582275(CHEMBL5081576)
Affinity DataIC50: 390nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
TargetMitogen-activated protein kinase kinase kinase 7(Human)
Rigel Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50582270(CHEMBL5084495)
Affinity DataIC50: 450nMAssay Description:Inhibition of TAK1 (unknown origin) in presence of MBP as substrate by ADP-Glo assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/5/2023
Entry Details Article
PubMed
Displayed 1 to 50 (of 56 total ) | Next | Last >>
Jump to: